These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Low Risk of Serological Cross-Reactivity between the Dengue Virus and SARS-CoV-2-IgG Antibodies Using Advanced Detection Assays. Shurrab FM; Al-Sadeq DW; Amanullah FH; Al-Absi ES; Qotba H; Yassine HM; Abu-Raddad LJ; Nasrallah GK Intervirology; 2022; 65(4):224-229. PubMed ID: 35134813 [TBL] [Abstract][Full Text] [Related]
6. Covert cases of Severe Acute Respiratory Syndrome Coronavirus 2: An obscure but present danger in regions endemic for Dengue and Chikungunya viruses. Stringari LL; de Souza MN; de Medeiros Junior NF; Goulart JP; Giuberti C; Dietze R; Ribeiro-Rodrigues R PLoS One; 2021; 16(1):e0244937. PubMed ID: 33406122 [TBL] [Abstract][Full Text] [Related]
7. Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests. Nath H; Mallick A; Roy S; Sukla S; Basu K; De A; Biswas S J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34110279 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections. Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500 [TBL] [Abstract][Full Text] [Related]
9. A Method To Prevent SARS-CoV-2 IgM False Positives in Gold Immunochromatography and Enzyme-Linked Immunosorbent Assays. Wang Q; Du Q; Guo B; Mu D; Lu X; Ma Q; Guo Y; Fang L; Zhang B; Zhang G; Guo X J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32277023 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity. Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092 [TBL] [Abstract][Full Text] [Related]
11. Low risk of serological cross-reactivity between dengue and COVID-19. Spinicci M; Bartoloni A; Mantella A; Zammarchi L; Rossolini GM; Antonelli A Mem Inst Oswaldo Cruz; 2020; 115():e200225. PubMed ID: 32813814 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Antibody Class-Specific SARS-CoV-2 Serologies for the Diagnosis of Acute COVID-19. Verkerke H; Horwath M; Saeedi B; Boyer D; Allen JW; Owens J; Arthur CM; Nakahara H; Rha J; Patel K; Wu SC; Paul A; Yasin N; Wang J; Shin S; Brown D; Normile K; Cole L; Meyers M; Lin H; Woods E; Isaac J; Broder K; Wade J; Kauffman RC; Patel R; Josephson CD; Reynolds S; Sherman M; Wrammert J; Alter D; Guarner J; Roback JD; Neish A; Stowell SR J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33468605 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis to characterize classes and subclasses of antibody responses to recombinant receptor-binding protein (RBD) of SARS-CoV-2 in COVID-19 patients in Thailand. Tandhavanant S; Koosakunirand S; Kaewarpai T; Piyaphanee W; Leaungwutiwong P; Luvira V; Chantratita N PLoS One; 2021; 16(8):e0255796. PubMed ID: 34375345 [TBL] [Abstract][Full Text] [Related]
14. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients. Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic. Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test. Nath H; Mallick A; Roy S; Kayal T; Ranjan S; Sengupta S; Sukla S; Biswas S Int J Infect Dis; 2022 Sep; 122():576-584. PubMed ID: 35811081 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies. Beavis KG; Matushek SM; Abeleda APF; Bethel C; Hunt C; Gillen S; Moran A; Tesic V J Clin Virol; 2020 Aug; 129():104468. PubMed ID: 32485620 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19. Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417 [TBL] [Abstract][Full Text] [Related]
19. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19. Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840 [TBL] [Abstract][Full Text] [Related]
20. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit. Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY mBio; 2020 Sep; 11(5):. PubMed ID: 32978311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]